Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Health care product for relieving alcoholic liver

A health care product and product technology, applied in the field of health care products for alleviating alcoholic liver, can solve problems such as ineffective effects, and achieve the effects of enhancing the body's immunity, promoting gluconeogenesis, and improving taste

Active Publication Date: 2011-05-18
SHENGQUAN HEALTANG
View PDF4 Cites 14 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] For this reason, the technical problem to be solved by the present invention is that there is an insignificant effect of relieving alcoholic liver in the anti-alcoholic liver health products in the prior art, so as to provide a health product for relieving alcoholic liver with a significant effect of relieving alcoholic liver

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Health care product for relieving alcoholic liver
  • Health care product for relieving alcoholic liver
  • Health care product for relieving alcoholic liver

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] Weigh 40g of L-arabinose, 15g of trehalose, 25g of fructooligosaccharide, 0.2g of selenium-enriched yeast, and 0.8g of magnesium stearate. After drying at 80°C, add 19g of mixed bacteria, mix evenly, and pack.

[0041] In the obtained product, L-arabinose accounts for 40% of the total mass of the product, trehalose accounts for 15% of the total mass of the product, mixed bacteria accounts for 19% of the total mass of the product, fructooligosaccharides accounts for 25% of the total mass of the product, selenium-enriched yeast Accounting for 0.2% of the total mass of the product, magnesium stearate accounts for 0.8% of the total mass of the product. Routine physical and chemical tests and microbial pathogen tests are carried out on the products, and the test results show that the products are qualified.

Embodiment 2

[0043] Weigh 30g of L-arabinose, 12g of trehalose, 30g of fructooligosaccharide, 5g of selenium-enriched yeast, and 8g of magnesium stearate. After drying, add 15g of mixed bacteria, mix evenly, and pack.

[0044] In the obtained product, L-arabinose accounts for 30% of the total mass of the product, trehalose accounts for 12% of the total mass of the product, mixed bacteria accounts for 15% of the total mass of the product, fructooligosaccharides accounts for 30% of the total mass of the product, selenium-enriched yeast It accounts for 5% of the total mass of the product, and magnesium stearate accounts for 8% of the total mass of the product. The product is subjected to routine physical and chemical inspection and microbial pathogenic bacteria inspection, and the inspection results show that the product is qualified.

Embodiment 3

[0046] Weigh 80g of L-arabinose, 1g of trehalose, 5g of fructooligosaccharide, 4g of selenium-enriched yeast, and 5g of magnesium stearate. After drying, add 5g of mixed bacteria, mix evenly, and pack.

[0047] in the obtained product. L-arabinose accounts for 80% of the total product mass, trehalose accounts for 1% of the total product mass, mixed bacteria accounts for 5% of the total product mass, fructooligosaccharides accounts for 5% of the total product mass, and selenium-enriched yeast accounts for the total product mass 4%, magnesium stearate 5% of the total product weight. Routine physical and chemical tests and microbial pathogen tests are carried out on the products, and the test results show that the products are qualified.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a health care product for relieving alcoholic liver, which comprises L-arabinose and mixed bacteria, and also comprises a food additive and / or pharmaceutic adjuvant. The problem of poor effect of relieving the alcoholic liver in the health care product for sobering up and protecting liver in the prior art is solved, therefore, the health care product for relieving the alcoholic liver, with remarkable effect for relieving the alcoholic liver, is provided.

Description

technical field [0001] The invention relates to a health product. Specifically, a health product for relieving alcoholic liver. Background technique [0002] Alcoholic liver is a common disease in modern society. Long-term excessive drinking can cause fatty degeneration, necrosis and regeneration of liver cells repeatedly through ethanol itself and its derivative acetaldehyde, leading to alcoholic liver disease, including alcoholic fatty liver, Alcoholic hepatitis, liver fibrosis, and cirrhosis. Alcoholic liver generally has no specific symptoms and signs in the early stage. As the disease progresses, some signs of digestive system and liver diseases appear, which will gradually lead to alcoholic hepatitis, liver fibrosis, and liver cirrhosis. Mild symptoms include abdominal distension, fatigue, discomfort in the liver area, anorexia, jaundice, hepatomegaly and tenderness, gloomy complexion, ascites, edema, spider angioma, fever, and leukocytosis (mainly neutrophilia). If...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A23L1/09A23L33/125A23L33/135
CPCA23V2002/00
Inventor 唐一林江成真张金柱丁继程马彩霞
Owner SHENGQUAN HEALTANG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products